FEMARA TABS 2.5mg (Letrozole)

Femara® Tablets 2.5 mg (Letrozole) are an aromatase inhibitor prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Letrozole works by reducing estrogen production in the body, which can slow or stop the growth of certain types of breast tumors that require estrogen to grow. Femara is typically used as part of a comprehensive treatment plan under the supervision of an oncologist or qualified healthcare professional. Regular medical monitoring is recommended to ensure safe and effective therapy.